Healthcare provider profile · identity verified

Steven W Etherton, DO

Family Practice · OAKLAND CITY, IN · NPI 1407951734

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	359	82
Levothyroxine Sodium	Levothyroxine Sodium	290	60
Omeprazole	Omeprazole	274	62
Losartan Potassium	Losartan Potassium	242	56
Furosemide	Furosemide	237	54
Gabapentin	Gabapentin	232	45
Metoprolol Succinate	Metoprolol Succinate	216	53
Amlodipine Besylate	Amlodipine Besylate	203	53
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	178	40
Lisinopril	Lisinopril	138	41
Rosuvastatin Calcium	Rosuvastatin Calcium	122	32
Hydrochlorothiazide	Hydrochlorothiazide	116	32
Atenolol	Atenolol	113	23
Tramadol Hcl	Tramadol Hcl	113	25
Pravastatin Sodium	Pravastatin Sodium	109	30
Simvastatin	Simvastatin	107	25
Metformin Hcl	Metformin Hcl	104	25
Tamsulosin Hcl	Tamsulosin Hcl	104	32
Famotidine	Famotidine	101	15
Potassium Chloride	Potassium Chloride	100	24
Meloxicam	Meloxicam	94	27
Clopidogrel	Clopidogrel Bisulfate	88	17
Venlafaxine Hcl Er	Venlafaxine Hcl	85	13
Escitalopram Oxalate	Escitalopram Oxalate	82	18
Pantoprazole Sodium	Pantoprazole Sodium	80	25
Trazodone Hcl	Trazodone Hcl	78	23
Eliquis	Apixaban	77	14
Albuterol Sulfate Hfa	Albuterol Sulfate	76	24
Montelukast Sodium	Montelukast Sodium	73	20
Jardiance	Empagliflozin	72	14
Fluticasone Propionate	Fluticasone Propionate	70	22
Lorazepam	Lorazepam	69	12
Metoprolol Tartrate	Metoprolol Tartrate	68	20
Carvedilol	Carvedilol	65	15
Metformin Hcl Er	Metformin Hcl	65	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	59	15
Sertraline Hcl	Sertraline Hcl	59	15
Duloxetine Hcl	Duloxetine Hcl	58	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	15
Ozempic	Semaglutide	58	suppressed
Bupropion Xl	Bupropion Hcl	57	13
Allopurinol	Allopurinol	53	13
Citalopram Hbr	Citalopram Hydrobromide	53	13
Alendronate Sodium	Alendronate Sodium	51	12
Alprazolam	Alprazolam	51	suppressed
Glipizide Er	Glipizide	51	16
Clonazepam	Clonazepam	49	suppressed
Aripiprazole	Aripiprazole	48	suppressed
Diclofenac Sodium	Diclofenac Sodium	46	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	46	13
Tizanidine Hcl	Tizanidine Hcl	46	suppressed
Methylprednisolone	Methylprednisolone	44	40
Isosorbide Mononitrate Er	Isosorbide Mononitrate	42	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	40	14
Zolpidem Tartrate	Zolpidem Tartrate	38	12
Buspirone Hcl	Buspirone Hcl	36	suppressed
Ropinirole Hcl	Ropinirole Hcl	33	suppressed
Spironolactone	Spironolactone	33	suppressed
Benazepril Hcl	Benazepril Hcl	32	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	31	suppressed
Finasteride	Finasteride	30	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Xarelto	Rivaroxaban	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Farxiga	Dapagliflozin Propanediol	28	suppressed
Myrbetriq	Mirabegron	27	suppressed
Novolog Flexpen	Insulin Aspart	27	suppressed
Propranolol Hcl	Propranolol Hcl	27	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	27	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	26	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	25	suppressed
Linzess	Linaclotide	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Topiramate	Topiramate	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Nitroglycerin	Nitroglycerin	21	13
Prazosin Hcl	Prazosin Hcl	21	suppressed
Prednisone	Prednisone	21	suppressed
Terazosin Hcl	Terazosin Hcl	21	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Humalog Kwikpen U-100	Insulin Lispro	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Amoxicillin	Amoxicillin	18	18
Entresto	Sacubitril/Valsartan	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Tresiba Flextouch U-100	Insulin Degludec	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Estradiol	Estradiol	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Primidone	Primidone	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	14
Torsemide	Torsemide	14	suppressed
Tradjenta	Linagliptin	14	suppressed
Trintellix	Vortioxetine Hydrobromide	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Colestipol Hcl	Colestipol Hcl	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Dexlansoprazole Dr	Dexlansoprazole	13	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	13	13
Ezetimibe	Ezetimibe	13	suppressed
Felbamate	Felbamate	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	12
Cephalexin	Cephalexin	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Temazepam	Temazepam	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Valsartan	Valsartan	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Ramipril	Ramipril	11	suppressed
Rexulti	Brexpiprazole	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error